1.8200 +0.35 (23.81%)
Pre-Market: 8:59AM EST
|Bid||1.6400 x 1300|
|Ask||1.7200 x 1300|
|Day's Range||1.4500 - 1.6500|
|52 Week Range||1.4000 - 8.0000|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.00|
TORONTO, Nov. 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCPK:SOLCF - News) (Frankfurt:9SB.F - News) announced today that its 40.7% owned portfolio company Heavenly Rx, Ltd. ("Heavenly Rx") has entered into a memorandum of understanding ("MOU") with the US NASDAQ listed public company, Therapix Biosciences Ltd (NASDAQ:TRPX - News), a speciality clinical-stage pharmaceutical company with a portfolio of technologies and assets based on cannabinoid pharmaceuticals, pursuant to which Therapix and Heavenly Rx have agreed to pursue a business combination. Pursuant to the MOU, the parties will negotiate a definitive agreement for a business combination between Therapix and Heavenly Rx, constituting a reverse takeover of Therapix by Heavenly Rx.
Cannabis News On Dec. 20, President Trump signed the Agriculture Improvement Act of 2018 into law, legalizing hemp in the U.S. Among other things, this new law changes certain federal authorities relating to the production and marketing of hemp, defined as cannabis (Cannabis sativa L.), and derivatives of cannabis with extremely low (less than 0.3% […] The post Cannabis Stock News Weekend Roundup December 23 appeared first on Market Exclusive.